2/26/2013

Business groups led by the U.S. Chamber of Commerce and the Pharmaceutical Research and Manufacturers of America are pressing the Alabama Supreme Court to reconsider its ruling that makes brand-name drugmakers liable for injuries caused by generic versions of their treatments. "By essentially absolving [generic-drug-makers] of any responsibility, you're saying they don't have to perform that job very carefully," PhRMA General Counsel Mit Spears said. In a separate court brief, the Chamber of Commerce said the decision "threatens to unleash the plaintiffs' bar on all manufacturers doing business in Alabama" and "eviscerates basic tort limitations."

Related Summaries